rfhg_106659.1

Basic information about the TSS

---

TSS ID: rfhg_106659.1 Species: human Chr: chr8		Start: 54022442 End: 54022454 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4093258,EH38E2631569)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000396401.7:0 ENST00000521604.7:0 ENST00000522397.5:0 GeneID: 6917 HGNC/MGI_ID: HGNC:11612 UniProt_ID: A0A384MTX4 P23193 Nearer transcript ids and distances: ENST00000640382.1:-2 ENST00000640041.1:-2 ENST00000519704.1:116 ENST00000518310.5:128 ENST00000517351.5:132 M81601:143 ENST00000522635.5:173 AK297729:173 ENST00000521086.6:177 BX538034:177 AK297957:179 AK026617:183 X57198:189 BC072460:191 GQ900953:191 X62585:213 ENST00000518784.5:283 ENST00000520534.5:294 AK290454:299 ENST00000640873.1:317 ENST00000638322.1:317 CR542221:317 view more...

Gene_name: transcription elongation factor A1 Gene_symbol: TCEA1 Gene_synonyms: SII TF2S TFIIS Gene_source: HGNC:11612

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NR_109902
Entrez ID:	6917
Nearest Unigene:	Hs.491745
Nearest Refseq:	NM_006756
Nearest Ensembl:	ENSG00000187735
Gene Name:	transcription elongation factor A1
Gene Alias:	GTF2S|SII|TCEA|TF2S|TFIIS
Gene Type:	protein-coding
CpG%:	0.083333
GC%:	0.692308
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TCEA1 p2@TCEA1 p3@TCEA1 p4@TCEA1 p5@TCEA1 p6@TCEA1
Sample		p1@TCEA1	p2@TCEA1	p3@TCEA1	p4@TCEA1	p5@TCEA1	p6@TCEA1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.93	5.65	18.12	0.97	3.12	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.31	5.06	18.61	0.81	2.63	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.15	5.79	18.13	1.16	2.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.90	7.07	18.30	1.87	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.97	5.62	17.32	2.02	1.35	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.72	3.88	21.13	1.55	1.16	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.64	6.32	21.57	1.74	1.74	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	12.35	7.27	19.86	2.66	1.94	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.69	7.48	14.11	2.35	2.35	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	17.97	8.11	20.87	3.48	2.32	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.30	4.04	19.40	2.43	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	7.72	34.15	3.25	1.22	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	21.92	1.93	0.16	0.32	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.34	2.86	0.45	0.00	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	20.86	1.10	0.66	0.44	0.22	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.57	2.51	0.50	1.26	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.85	1.75	0.44	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.19	1.69	0.42	0.42	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.93	1.07	0.00	0.53	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	21.51	3.16	0.15	0.60	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.58	1.74	0.40	0.40	0.53	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.05	1.90	0.35	0.69	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.06	2.46	0.26	0.39	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.71	2.67	0.49	1.21	0.24	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.58	2.06	0.52	0.52	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	17.09	0.32	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.89	1.65	0.00	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	19.10	2.12	1.18	0.24	1.18	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.80	2.26	0.65	0.48	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.64	3.08	0.18	0.54	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.12	1.67	1.05	0.21	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.87	0.98	0.20	0.39	0.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	18.36	1.90	0.84	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14.68	1.48	0.66	0.82	0.33	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.20	2.24	0.75	0.37	1.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.67	1.15	0.57	0.77	0.77	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	18.19	2.04	0.82	0.20	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.90	2.22	0.40	0.60	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	21.88	3.24	0.81	0.54	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.80	2.40	0.24	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.47	2.12	0.94	0.47	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.96	1.90	0.44	0.59	1.17	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.35	1.05	0.21	0.00	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.96	2.27	0.52	0.70	1.22	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	23.89	2.01	1.00	0.80	0.00	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.98	2.09	0.23	0.47	1.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.48	3.60	0.24	0.48	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.99	2.68	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.60	2.63	0.72	0.24	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.76	2.22	0.20	0.61	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.71	1.64	0.20	0.41	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.45	0.89	0.00	0.89	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	41.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.36	2.13	0.35	0.71	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.94	0.99	0.66	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	13.42	5.03	1.68	2.52	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.18	0.92	0.46	0.00	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	2.92	0.32	0.65	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.78	1.93	0.00	0.32	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.12	1.26	0.63	0.00	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	0.71	0.71	0.00	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	2.80	1.12	0.56	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	1.59	0.80	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.85	1.36	0.68	0.34	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.42	2.60	0.97	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.87	1.77	0.35	1.42	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33	64.66	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	7.90	15.79	7.90	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	3.41	0.98	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	2.98	1.49	0.50	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.26	3.75	0.47	1.41	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.91	2.65	0.33	0.00	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	2.17	0.62	0.62	0.62	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.15	2.75	0.92	0.61	0.31	1.22
Adipocyte - breast, donor1	11376-118A8	20.43	11.56	12.04	3.17	0.95	3.80
Adipocyte - breast, donor2	11327-117E4	15.72	8.50	4.33	1.93	1.60	1.60
Adipocyte - omental, donor1	11473-119C6	24.17	15.65	26.85	6.62	2.42	7.63
Adipocyte - omental, donor2	11474-119C7	8.97	7.47	5.23	0.00	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	16.75	12.73	7.37	4.02	1.00	2.01
Adipocyte - perirenal, donor1	11476-119C9	10.85	10.21	7.02	5.10	0.64	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	3.30	3.30	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	10.84	7.68	7.23	1.35	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.52	4.52	0.87	1.39	0.52	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	37.55	7.04	5.87	2.15	3.32	3.13
Adipocyte differentiation, day04, donor2	13022-139D7	15.70	3.35	1.80	0.51	0.51	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	25.37	8.64	8.92	4.46	2.79	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	31.15	13.52	10.58	5.88	2.94	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	22.36	5.39	2.49	1.93	1.13	2.09
Adipocyte differentiation, day08, donor2	13023-139D8	17.43	9.68	3.23	0.32	1.29	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	5.87	2.67	1.60	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	4.45	1.11	2.23	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	12.06	2.08	2.08	0.83	0.42	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	12.81	4.77	1.51	1.26	1.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	8.51	2.29	1.96	0.65	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	10.96	3.35	0.91	1.22	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	3.98	3.31	1.10	0.88	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	2.51	1.43	0.72	1.79	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.40	1.44	0.54	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.31	1.03	0.00	0.82	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	13.04	4.92	0.69	1.03	0.57	0.23
Anulus Pulposus Cell, donor2	11463-119B5	11.27	3.67	0.49	1.47	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	3.15	3.15	1.35	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	8.25	7.81	4.78	2.17	2.17	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.16	5.98	3.29	0.90	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	2.53	5.06	0.00	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	3.96	3.30	0.66	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.45	4.55	3.57	0.32	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	5.34	2.91	1.46	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.69	3.56	1.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	6.78	2.64	0.75	0.38	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	6.53	3.63	1.45	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	1.25	3.76	2.51	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.03	4.94	3.13	1.48	1.48	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	6.82	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.99	3.47	3.32	0.30	0.90	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.11	6.43	3.21	1.61	1.61	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.20	3.97	3.97	1.51	0.76	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.68	1.60	1.87	2.14	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	4.88	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.12	3.65	1.82	1.16	0.33	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	1.20	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.95	4.63	1.54	1.20	0.69	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.31	3.40	2.43	1.46	0.49	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.21	3.04	2.28	1.14	0.00	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	6.06	3.63	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	7.98	1.71	1.14	2.85	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.62	6.63	3.42	0.64	0.00	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.42	4.65	2.58	0.77	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.85	4.22	2.35	1.41	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.22	3.86	1.61	1.61	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	3.57	2.85	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.60	5.85	4.09	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.03	3.91	3.31	0.90	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	3.56	3.56	1.19	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.59	5.59	2.03	1.02	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.62	3.82	2.80	0.76	0.76	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	6.35	1.27	2.54	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.63	6.04	1.29	0.86	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.16	5.50	1.27	0.21	0.64	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.38	3.19	2.61	0.58	0.29	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	2.83	2.83	0.94	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	9.15	2.54	2.03	1.86	0.51	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	4.23	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.65	6.43	2.14	1.07	0.86	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.02	2.41	2.41	1.80	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	2.19	2.19	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.74	3.45	1.61	1.15	0.69	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	5.10	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.12	3.05	1.53	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.46	5.57	2.48	1.45	0.83	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.65	3.37	1.84	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	4.30	1.43	0.48	1.43	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.42	4.43	2.66	0.89	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	6.10	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	4.98	3.88	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.27	5.30	2.65	0.79	0.53	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.18	5.09	1.45	1.45	1.45	2.18
Astrocyte - cerebellum, donor1	11500-119F6	6.51	1.84	1.23	0.25	0.74	0.00
Astrocyte - cerebellum, donor2	11580-120F5	3.42	0.86	0.34	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	5.03	3.15	0.84	0.42	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	33.46	5.23	1.74	1.74	2.44	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	26.21	7.44	5.82	1.13	2.43	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	31.03	4.92	2.83	0.60	1.04	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	55.39	9.98	2.18	3.10	3.21	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	54.12	8.77	2.26	2.88	2.63	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	53.71	11.61	5.23	2.28	2.73	0.34
Basophils, donor1	12241-129G9	8.63	6.80	0.26	1.57	0.00	0.00
Basophils, donor2	12242-129H1	27.06	12.99	1.08	3.97	0.36	0.00
Basophils, donor3	12243-129H2	15.29	8.08	0.29	1.62	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	1.94	1.51	0.22	0.65	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	0.00	0.00	1.37	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	14.35	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	4.39	1.88	1.26	1.88	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	5.41	3.33	1.04	1.46	0.83	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	14.97	11.98	7.60	6.22	1.15	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	15.30	9.00	1.44	2.34	1.44	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	83.37	30.20	47.92	3.50	6.18	2.27
Burkitt's lymphoma cell line:RAJI	10476-106I8	130.66	17.70	25.85	4.19	15.60	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	29.42	6.72	2.88	0.64	0.64	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	18.60	5.64	0.56	3.94	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	15.22	8.91	1.48	3.34	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	19.76	5.93	0.88	1.54	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	22.36	9.62	0.00	1.98	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.43	8.72	1.14	1.14	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.61	9.20	0.33	2.63	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	9.54	10.41	1.01	3.04	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	9.96	9.96	0.00	2.11	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	8.77	8.53	0.24	1.18	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.53	7.53	0.67	3.01	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.42	4.42	0.83	0.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.96	5.45	1.24	0.74	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.70	6.85	0.39	1.37	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.52	4.27	0.53	1.25	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.13	9.36	1.09	2.18	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.79	5.38	0.47	1.40	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.28	6.34	0.53	3.70	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	1.11	1.11	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.40	7.29	0.74	2.38	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.79	3.39	0.60	2.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.66	7.70	3.75	2.08	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.09	4.12	0.23	1.83	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.43	5.20	1.13	2.04	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.42	4.36	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	7.80	6.46	0.54	1.08	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	9.60	4.88	0.35	2.09	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.57	6.31	1.26	3.37	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.33	7.35	1.47	2.76	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.58	4.23	3.17	3.87	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.83	8.34	2.19	1.75	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.06	4.71	0.35	1.22	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.20	4.83	1.12	0.37	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.60	6.47	0.22	1.51	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.01	7.37	1.23	2.05	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.40	3.94	3.01	3.01	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.73	6.03	1.86	2.55	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	9.59	10.03	0.87	3.27	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	10.86	9.24	0.46	4.85	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	9.96	9.10	0.00	4.12	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	16.20	14.95	0.16	4.52	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	13.10	12.92	0.52	4.02	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	19.84	16.05	0.22	4.01	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	8.93	4.85	0.51	2.81	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	15.15	9.44	0.66	2.85	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	10.32	8.42	0.00	3.37	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	24.39	2.03	2.03	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	63.05	7.46	2.03	2.03	2.03	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	51.78	10.36	4.14	4.14	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	55.97	9.59	5.86	3.20	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	85.77	17.69	1.61	3.75	0.54	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	61.77	15.44	2.11	3.51	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	62.75	9.41	3.14	3.92	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	75.14	7.91	0.00	5.27	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	28.77	7.40	1.64	2.47	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	26.84	8.71	2.18	0.73	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	38.37	9.09	3.53	2.02	1.51	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	147.08	20.20	35.56	6.46	8.08	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	95.08	15.18	19.97	3.20	3.99	1.20
CD34+ Progenitors, donor1	11545-120B6	15.06	5.02	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	17.42	7.30	0.56	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	34.95	4.13	2.63	1.13	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	33.60	7.89	2.93	0.68	1.80	0.68
CD4+ T Cells, donor1	11225-116C1	51.06	10.00	1.79	1.43	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	37.97	7.35	0.00	5.51	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	35.99	8.54	0.91	1.22	0.61	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	27.57	8.17	0.26	1.53	0.77	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	34.36	7.41	0.90	2.92	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	31.05	9.49	0.57	0.86	1.15	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.55	12.33	0.95	0.47	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	32.31	7.02	0.00	2.81	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	13.18	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	24.42	14.02	1.16	2.31	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.37	7.12	0.68	2.37	0.51	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	25.63	10.48	0.64	2.42	0.64	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	35.42	10.31	1.34	2.24	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	34.94	15.02	1.40	4.19	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	37.84	13.64	1.76	4.40	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	20.66	10.54	1.26	2.53	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.53	6.23	0.42	2.91	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.38	6.01	0.33	2.00	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	34.26	10.06	0.82	2.72	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	34.84	10.18	1.07	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	3.59	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.26	13.17	1.85	2.78	0.74	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	26.64	5.85	0.65	1.73	0.65	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.90	6.72	0.84	2.52	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	36.91	10.11	0.00	1.52	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	29.46	7.80	0.87	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	46.20	6.97	0.87	0.87	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.45	12.37	0.49	4.45	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	38.77	8.31	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	39.08	5.58	0.00	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	38.77	10.80	0.83	4.98	1.94	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	54.72	11.78	0.98	3.19	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	52.36	10.78	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	54.79	12.89	0.00	2.51	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	49.86	6.92	1.38	1.38	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	38.96	8.51	0.98	0.65	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	32.66	4.51	1.13	2.25	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	45.70	7.32	1.51	1.01	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	15.83	3.21	4.82	1.38	1.61	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.06	2.88	4.07	1.68	2.88	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.33	3.83	4.65	0.55	0.55	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.81	3.90	3.00	0.60	0.90	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.60	3.36	4.56	0.72	0.96	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.60	2.96	6.14	0.91	0.91	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	16.95	3.69	4.78	0.87	1.30	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.79	5.00	8.16	1.84	1.58	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.37	4.22	5.86	1.41	0.70	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.02	4.83	13.28	1.21	1.81	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	17.72	4.36	10.75	1.74	1.74	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.99	2.66	9.33	0.80	1.87	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.82	5.69	21.89	2.19	1.75	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	24.14	7.29	25.50	4.10	3.64	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	5.22	21.63	2.24	0.75	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	17.65	3.96	3.96	0.72	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.52	2.30	5.47	0.58	0.86	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.33	2.83	2.59	1.41	0.47	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	14.26	4.12	6.34	0.32	1.58	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	3.38	8.00	1.23	1.54	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.11	3.53	8.01	0.96	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	24.86	4.59	18.36	2.29	1.15	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	15.76	5.91	14.98	2.76	3.94	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.99	5.29	14.37	3.78	2.27	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	55.40	19.27	53.00	5.62	3.21	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	62.25	8.39	63.65	10.49	7.69	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	57.10	24.04	60.11	13.02	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	1.83	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	7.91	4.45	0.00	1.98	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	30.31	13.89	19.78	2.10	2.42	2.42
Chondrocyte - de diff, donor1	11261-116G1	29.12	14.21	15.95	2.08	4.85	2.08
Chondrocyte - de diff, donor2	11338-117F6	15.64	16.70	8.17	3.55	1.07	2.13
Chondrocyte - de diff, donor3	11410-118E6	27.99	13.54	8.08	2.96	2.16	4.21
Chondrocyte - re diff, donor2	11339-117F7	26.86	6.27	12.53	4.48	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	22.65	7.28	5.66	0.40	0.40	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	22.84	5.39	1.84	0.80	1.03	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	20.31	4.06	1.28	0.43	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	20.71	4.16	1.15	0.35	0.71	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.43	3.58	1.01	1.65	2.02	0.18
Corneal Epithelial Cells, donor1	11526-119I5	3.73	3.07	0.66	0.88	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.09	3.07	0.26	0.26	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.54	5.78	0.17	2.31	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	14.82	3.15	0.32	1.26	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	11.12	4.64	0.32	1.08	0.43	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	37.92	6.49	3.42	2.39	1.71	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	52.23	6.53	4.57	3.26	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.97	11.61	4.36	1.94	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	16.34	6.00	5.00	1.83	0.83	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	9.39	5.28	3.52	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	12.16	5.94	3.11	1.13	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	17.69	7.86	2.36	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	3.49	2.62	1.75	1.75	0.29	0.87
Endothelial Cells - Artery, donor2	11341-117F9	12.94	5.65	3.29	1.41	1.41	0.00
Endothelial Cells - Artery, donor3	11413-118E9	11.40	3.16	1.23	0.35	0.53	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.85	3.55	0.44	1.11	0.44	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	3.96	1.22	0.30	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.53	3.66	1.41	1.13	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	4.46	0.89	0.89	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	6.77	5.21	0.52	1.56	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	7.37	1.13	0.85	0.14	0.57	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	18.01	9.60	6.80	1.20	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	1.57	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	29.82	7.95	4.85	0.99	0.99	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.63	6.30	3.04	1.09	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	38.35	11.11	5.01	1.83	1.59	0.12
Endothelial Cells - Vein, donor1	11267-116G7	6.83	6.83	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	2.79	5.59	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	13.50	4.55	3.93	0.47	0.63	0.16
Eosinophils, donor1	12244-129H3	60.99	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	10.70	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.20	1.22	0.49	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	4.16	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	37.36	19.70	23.40	3.69	4.93	9.03
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.49	7.23	3.61	1.53	0.33	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.23	13.87	12.57	5.09	1.84	2.38
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.44	11.28	10.07	2.91	0.97	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.69	4.78	10.10	3.28	0.96	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	24.15	18.25	13.71	3.48	2.11	3.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.12	8.70	21.61	3.43	2.37	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	29.90	14.95	11.29	1.99	2.99	1.33
Fibroblast - Cardiac, donor1	11268-116G8	18.15	4.08	6.35	0.91	2.27	0.45
Fibroblast - Cardiac, donor2	11345-117G4	6.82	5.31	3.79	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.99	4.42	2.05	0.79	0.79	1.42
Fibroblast - Cardiac, donor4	11452-119A3	20.01	6.67	4.55	0.61	0.61	1.21
Fibroblast - Cardiac, donor5	11456-119A7	29.82	21.19	13.83	4.95	2.41	1.27
Fibroblast - Cardiac, donor6	11460-119B2	17.58	5.61	3.18	1.36	0.91	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.30	2.81	0.13	0.80	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	1.29	0.86	0.00	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	4.39	1.46	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.22	9.46	9.69	2.54	3.69	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	26.29	6.78	1.36	2.04	0.68	0.51
Fibroblast - Dermal, donor1	11269-116G9	10.57	8.22	1.88	0.94	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	11.32	3.30	3.77	0.94	2.36	0.00
Fibroblast - Dermal, donor3	11418-118F5	17.29	5.92	0.97	1.33	0.97	0.85
Fibroblast - Dermal, donor4	11450-119A1	27.81	13.00	3.84	2.60	1.36	0.57
Fibroblast - Dermal, donor5	11454-119A5	29.66	15.70	9.77	2.79	2.97	0.70
Fibroblast - Dermal, donor6	11458-119A9	25.50	13.48	3.57	1.95	2.11	0.49
Fibroblast - Gingival, donor1	11237-116D4	18.32	5.83	1.67	2.08	0.00	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.17	6.81	7.60	1.31	1.31	3.14
Fibroblast - Gingival, donor2	11318-117D4	20.69	6.72	1.58	0.79	1.05	0.13
Fibroblast - Gingival, donor3	11394-118C8	46.02	10.73	6.48	4.83	2.42	1.64
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	32.21	7.27	6.23	1.04	4.16	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.00	17.27	13.57	5.81	4.05	3.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	21.05	5.30	1.87	0.94	1.71	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.37	8.11	2.16	0.95	0.95	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	5.65	2.12	0.35	1.41	0.00	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.23	4.09	1.02	1.17	0.88	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.45	6.41	2.59	0.82	0.82	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	30.82	8.12	9.87	2.19	2.08	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	30.67	12.62	7.19	2.93	2.79	4.99
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	7.46	5.97	0.00	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	23.21	3.59	2.11	1.27	0.84	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	4.17	4.17	0.83	3.33	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	4.20	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	1.40	1.96	0.28	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	7.71	8.53	2.03	1.62	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.74	8.15	3.30	0.78	0.58	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	32.46	12.59	2.28	1.52	1.37	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.03	12.24	3.98	3.37	1.84	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.32	6.49	4.96	1.91	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.65	5.94	3.24	2.43	1.08	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	33.75	17.05	8.47	3.60	2.67	2.44
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.80	8.51	4.31	1.66	1.11	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.91	4.67	2.03	1.22	1.42	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	3.34	1.34	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.86	3.56	0.40	0.40	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.95	4.76	8.14	1.39	1.39	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	29.31	17.05	15.45	3.91	3.91	5.68
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	26.61	16.56	14.78	5.12	2.37	2.96
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.52	1.81	8.12	0.30	0.60	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	23.75	14.47	8.20	3.45	2.48	2.27
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	16.96	7.09	15.18	2.02	2.28	0.25
Fibroblast - skin normal, donor1	11553-120C5	22.31	14.60	12.31	3.61	2.30	3.94
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.64	3.01	13.63	1.60	2.21	0.80
Fibroblast - skin normal, donor2	11561-120D4	28.03	12.36	14.27	3.01	4.82	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	10.88	4.53	8.46	1.81	1.21	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	32.14	22.70	12.76	5.88	2.73	5.63
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.91	15.90	5.98	3.93	1.03	4.10
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.84	3.28	7.23	0.33	1.64	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.85	7.67	5.75	1.17	2.24	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	13.66	3.71	2.70	0.34	1.01	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.68	8.94	6.43	2.67	1.88	3.45
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	66.48	0.00	0.00	44.32	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	5.23	0.00	1.74	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.48	8.84	5.03	2.25	1.04	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.40	7.81	5.47	1.30	2.08	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.24	10.22	5.88	4.34	2.04	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	25.26	12.25	1.53	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.80	22.97	29.99	5.74	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	53.91	52.77	25.96	16.83	5.13	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	47.43	8.82	2.76	4.14	1.93	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	32.65	9.59	3.65	4.11	2.05	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	35.86	31.70	18.23	5.94	2.77	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	50.75	11.10	4.23	2.91	2.11	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.61	3.59	4.89	3.26	1.30	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	36.26	50.41	20.34	17.25	2.65	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	50.31	53.56	76.31	51.30	7.63	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	44.08	57.88	89.52	49.63	9.85	2.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	41.64	69.84	96.97	41.64	9.67	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.42	48.44	62.32	54.27	5.20	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	41.94	96.62	116.69	108.53	6.78	2.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	29.68	91.49	102.26	95.96	7.32	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.47	27.15	29.66	23.50	3.65	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.77	46.21	73.12	44.47	7.22	2.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.66	74.32	83.28	79.12	5.90	2.62
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.07	14.48	16.55	7.39	1.48	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	33.70	23.53	40.53	14.62	4.29	2.38
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.31	54.74	100.99	58.76	6.70	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	25.41	10.69	6.86	3.43	1.61	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.86	12.38	15.95	5.77	1.36	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	27.75	24.83	45.67	18.71	3.55	1.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.83	5.51	4.27	2.91	1.56	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.79	4.78	3.93	2.39	0.85	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.55	6.09	7.75	2.43	1.99	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.12	13.31	19.47	7.07	2.25	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.66	15.11	21.64	7.55	1.43	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.14	3.92	4.13	0.62	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.02	5.42	4.04	0.81	1.27	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.68	5.67	3.50	2.33	1.00	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	21.60	5.07	2.42	1.54	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.32	5.66	3.07	1.72	0.98	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.07	5.84	3.40	1.78	1.95	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.53	6.09	2.89	2.25	1.92	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	23.03	4.07	2.08	1.23	0.95	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.14	4.90	1.90	0.79	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	18.85	3.95	3.04	1.52	2.13	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.12	3.45	1.25	1.05	1.15	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.42	2.63	1.32	0.88	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	18.80	3.93	2.24	0.84	1.12	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.04	3.43	1.02	0.65	0.56	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.97	2.14	1.34	0.53	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.29	4.74	4.13	0.61	1.07	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.32	3.76	1.68	0.65	1.04	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	16.54	2.71	1.36	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	20.65	2.95	0.92	0.55	1.29	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.01	3.07	1.32	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	2.98	0.99	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.96	4.62	1.58	0.79	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.19	3.43	0.81	1.82	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	22.11	6.35	0.76	2.29	1.02	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	62.31	135.56	174.18	112.87	14.93	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	64.25	82.89	139.59	92.29	13.10	3.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	65.47	79.79	111.09	59.53	13.71	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	27.22	32.23	25.03	12.52	3.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	17.24	35.60	22.04	7.91	1.13	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	37.82	38.28	19.37	19.37	3.23	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	64.34	42.07	44.55	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	32.88	44.48	31.33	25.92	2.71	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	27.28	33.69	38.51	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	26.08	26.08	12.17	34.78	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	29.94	33.52	16.60	23.76	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	32.12	30.89	13.18	17.30	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	29.99	0.00	29.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.36	14.26	9.23	8.95	1.40	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	27.13	23.86	13.73	17.32	2.29	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	20.97	20.13	4.19	7.55	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	24.49	14.63	8.59	6.04	1.27	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	25.81	16.64	9.17	11.89	1.36	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	33.22	12.03	4.58	3.44	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.09	10.06	2.37	2.96	2.07	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	15.25	5.08	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	22.37	12.43	3.73	2.90	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.93	12.66	2.53	3.45	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	15.81	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.99	6.15	1.54	2.69	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.82	8.80	2.28	2.61	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.71	8.69	4.01	2.68	1.34	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	21.58	12.71	2.31	3.47	4.24	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	24.99	8.90	5.14	2.40	1.37	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	14.91	4.97	7.45	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	32.09	14.63	0.47	0.94	1.42	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.71	12.67	1.21	3.02	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	31.54	14.75	1.53	2.54	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.54	7.18	1.60	2.39	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	34.04	14.31	3.45	3.45	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	23.61	14.17	3.54	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	25.09	6.42	2.33	1.17	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	26.33	17.99	1.32	3.51	2.19	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	10.17	0.85	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.74	4.18	1.79	1.79	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.01	5.82	1.46	0.97	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.40	2.49	0.42	0.83	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	1.12	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.93	6.66	0.63	0.63	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	3.76	0.00	0.00	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.80	9.75	4.99	2.55	1.74	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	18.06	12.49	8.44	3.54	2.03	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	17.75	10.24	4.78	0.91	1.14	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.16	7.65	4.37	2.08	1.64	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.13	9.03	6.45	2.36	1.72	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	20.02	9.90	6.46	1.29	1.51	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	17.68	9.09	5.11	1.49	1.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	16.47	9.61	6.86	1.54	2.06	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.94	6.41	5.77	1.28	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.92	1.68	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	1.73	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	10.58	7.93	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	3.17	2.82	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.18	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.48	7.69	8.22	1.22	1.22	0.52
Hepatocyte, donor1	11523-119I2	20.58	2.42	1.21	1.21	2.42	1.21
Hepatocyte, donor2	11603-120I1	23.70	5.39	12.93	3.23	3.23	1.08
Hepatocyte, donor3	11684-122I1	27.00	9.20	3.68	1.84	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	54.17	15.01	11.10	1.31	5.22	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	36.35	11.36	8.04	3.15	2.97	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.29	4.25	1.92	0.82	0.82	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	0.00	5.54	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	12.51	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	6.50	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	5.00	3.33	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63	7.26	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	2.65	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	0.00	2.22	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	15.71	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.34	1.89	6.93	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	1.55	6.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	1.94	3.23	1.29	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	3.22	4.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	9.78	0.81	3.26	1.63	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.46	1.26	2.94	0.00	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	14.47	1.61	2.41	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.93	0.92	2.77	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.97	1.42	2.83	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	0.00	2.72	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	29.48	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	0.00	0.00	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	1.27	1.27	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	0.64	2.55	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	3.65	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	3.57	2.86	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	6.64	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.04	1.85	0.93	0.31	1.54	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	3.51	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	12.52	2.09	0.70	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	24.34	0.00	6.64	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	3.24	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	18.31	1.74	5.23	0.00	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	9.00	9.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	32.00	2.13	1.07	1.07	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	2.77	2.77	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	2.85	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	4.60	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	12.42	12.42	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	3.17	7.40	2.11	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	9.14	5.88	2.94	3.18	0.57	0.24
Keratinocyte - epidermal, donor2	11349-117G8	7.03	4.69	4.10	3.51	1.76	0.00
Keratinocyte - epidermal, donor3	11421-118F8	30.29	14.29	10.41	3.60	3.03	0.19
Keratinocyte - oral, donor1	11251-116E9	31.67	10.22	2.38	3.75	1.02	1.14
Keratocytes, donor1	11527-119I6	15.47	8.60	11.69	5.50	2.41	1.38
Keratocytes, donor2	11607-120I5	9.37	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	53.75	30.43	18.97	9.09	3.75	2.17
Krukenberg tumor cell line:HSKTC	10687-109F3	54.95	4.40	17.58	4.40	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	6.47	2.16	0.00	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	27.45	3.46	1.38	1.15	1.61	0.12
Lens Epithelial Cells, donor3	11690-122I7	27.14	8.38	6.86	1.41	1.51	1.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.03	3.08	1.30	0.47	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.70	0.84	1.12	0.28	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.44	2.52	0.79	0.79	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.38	2.69	1.61	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	0.63	0.63	0.95	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.04	0.86	0.32	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	2.46	0.82	0.41	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.02	1.26	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.19	1.69	0.99	0.00	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	2.37	1.58	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.34	1.55	1.74	0.00	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.70	0.74	0.19	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.80	2.79	1.74	0.35	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.49	2.15	2.15	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.85	1.65	0.27	0.14	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.32	3.70	0.62	0.92	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	1.25	2.18	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.04	2.20	0.37	0.18	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.89	1.65	0.99	0.33	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.39	0.59	0.29	1.46	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.99	1.49	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.79	2.42	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.81	1.89	1.62	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.75	1.06	0.61	0.61	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	2.07	1.04	1.56	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.96	2.30	1.68	0.84	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.81	1.05	0.45	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	4.82	1.38	2.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.77	1.32	1.13	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.88	1.59	0.32	0.21	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.78	2.91	1.45	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.27	2.32	1.32	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.71	1.36	0.50	0.12	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.81	2.96	2.22	1.11	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.44	1.98	1.98	0.99	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.61	0.82	0.14	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	2.25	2.57	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.26	1.83	1.22	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.26	2.10	0.84	0.28	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	10.31	3.91	1.07	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.33	1.45	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.49	0.78	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.37	1.79	1.43	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.86	1.96	3.27	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.30	0.94	0.47	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.29	1.61	2.35	0.74	0.62	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.31	1.02	0.77	1.02	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.18	0.60	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	6.80	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	6.90	3.07	2.30	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	3.71	6.68	0.00	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.04	4.65	0.42	0.42	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	4.22	0.70	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	1.87	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	5.67	2.06	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	4.76	3.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.27	4.98	0.45	0.90	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.43	6.40	1.45	2.04	1.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.90	6.75	1.80	1.80	3.60	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.35	5.69	1.90	1.22	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.27	4.11	3.59	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.00	8.82	0.71	1.41	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	6.00	1.33	0.67	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.64	4.58	3.06	0.51	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.54	8.54	1.87	2.13	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.71	10.01	3.02	0.94	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.04	3.07	0.61	0.61	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	3.26	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	9.37	6.46	2.92	1.67	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	8.97	8.13	3.08	3.08	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	8.24	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.61	9.00	2.03	2.32	1.74	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.97	9.86	1.49	3.29	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	6.09	3.87	1.66	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.96	5.66	1.77	1.06	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	10.33	3.69	1.11	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	4.61	4.61	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.06	5.76	1.15	1.15	1.92	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	4.53	2.83	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	4.92	0.82	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.33	5.42	3.16	2.26	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.18	10.05	1.44	0.72	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	9.71	1.49	0.75	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.06	6.69	1.11	3.34	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	5.60	5.60	1.72	1.29	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	6.85	4.28	2.57	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.66	6.66	2.00	1.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.83	7.84	0.60	0.60	2.41	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	4.27	0.71	1.42	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.25	5.16	0.69	1.03	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	4.29	1.61	3.22	2.68	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	6.06	2.02	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.26	7.78	1.48	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	10.47	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	7.40	2.12	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.00	4.80	2.80	2.40	2.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6.54	4.36	2.18	1.45	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.20	1.53	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.41	3.45	0.99	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	4.70	1.88	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.06	1.51	3.52	0.50	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.21	3.15	0.45	2.25	2.25	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1.72	3.44	0.00	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.46	7.57	1.34	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7.82	5.47	1.56	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1.32	1.98	1.32	1.98	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	8.82	4.67	3.11	1.04	2.59	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.19	9.19	0.44	3.50	3.50	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	9.50	7.83	2.24	3.91	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.39	3.53	1.77	0.88	2.21	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.56	7.33	2.31	1.16	1.93	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.65	5.57	1.52	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.65	7.69	3.36	2.88	1.92	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	5.96	3.98	3.18	2.39	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.68	9.11	2.43	2.43	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	4.84	3.46	2.08	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	6.08	5.32	2.28	1.14	1.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	8.26	4.13	1.55	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	7.26	1.21	1.81	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.04	6.97	1.90	1.27	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	6.93	3.73	3.20	1.60	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	5.17	2.87	3.45	2.87	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3.60	4.63	0.51	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	8.49	4.24	2.83	3.54	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	3.40	6.81	1.13	2.27	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	6.24	2.08	1.66	2.08	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.83	7.83	3.92	1.57	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	4.18	5.85	2.09	0.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.04	4.18	0.93	1.39	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	4.01	5.35	4.68	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.09	8.55	2.14	1.07	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	6.87	5.66	0.81	2.83	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3.67	3.67	4.59	2.75	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	8.00	3.56	2.67	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	3.42	6.27	1.14	1.14	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	11.50	3.07	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	4.38	7.11	1.64	1.64	2.74	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.03	6.24	2.67	2.23	1.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.58	5.46	3.90	1.56	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.29	6.63	1.99	0.66	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	2.08	6.24	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.04	7.75	0.68	1.60	0.23	0.46
Macrophage - monocyte derived, donor2	11313-117C8	8.81	4.77	0.18	0.92	0.73	0.00
Macrophage - monocyte derived, donor3	11389-118C3	13.11	4.72	1.18	0.92	0.66	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.31	4.25	3.19	1.59	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	12.20	5.70	1.43	0.32	1.43	0.16
Mallassez-derived cells, donor3	11930-125I4	10.84	9.45	5.42	0.97	1.11	0.69
Mammary Epithelial Cell, donor1	11273-116H4	40.75	20.03	14.75	7.47	3.49	1.89
Mammary Epithelial Cell, donor2	11350-117G9	24.32	13.61	13.03	6.95	3.19	0.58
Mammary Epithelial Cell, donor3	11422-118F9	8.73	2.74	0.50	0.50	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	40.00	11.52	8.14	0.68	2.03	0.00
Mast cell, donor1	11563-120D6	30.17	10.49	2.38	2.81	0.97	0.43
Mast cell, donor2	11565-120D8	27.34	12.48	1.19	3.57	0.30	0.00
Mast cell, donor3	11566-120D9	31.07	11.71	0.45	3.38	0.90	0.00
Mast cell, donor4	11567-120E1	20.92	12.41	1.24	4.96	0.89	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	26.28	7.21	1.11	1.89	0.67	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	25.10	7.00	6.42	1.75	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	25.47	8.15	1.03	2.64	1.15	0.11
Mast cell, expanded, donor8	11941-126A6	25.11	10.88	1.67	4.35	0.67	0.84
Melanocyte - dark, donor1	11502-119F8	17.61	3.58	1.49	0.60	0.30	0.30
Melanocyte - dark, donor2	11582-120F7	8.65	3.81	2.08	0.69	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	21.23	2.68	1.74	0.51	1.16	0.58
Melanocyte - light, donor1	11274-116H5	4.94	0.71	0.47	0.24	0.71	0.00
Melanocyte - light, donor2	11351-117H1	3.41	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	0.00	0.87	1.73	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	17.08	4.69	0.73	0.62	1.25	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	9.68	2.69	1.88	0.27	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	15.00	2.41	1.87	0.27	0.80	0.27
Meningeal Cells, donor1	11493-119E8	8.06	3.60	2.36	1.49	0.87	0.25
Meningeal Cells, donor2	11573-120E7	14.52	2.64	1.76	0.88	0.88	0.44
Meningeal Cells, donor3	11654-122E7	19.32	7.34	3.83	1.39	0.82	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	23.38	3.71	2.00	0.86	0.86	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.60	7.95	8.05	2.01	0.91	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.18	8.61	2.87	2.15	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.42	11.86	8.26	1.69	2.54	3.60
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	18.10	7.04	4.52	1.01	1.01	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	3.74	3.08	0.66	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	2.92	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.30	1.64	0.20	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.25	3.46	0.42	0.42	0.55	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	0.00	1.12	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.29	6.45	4.34	1.97	1.71	1.97
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.23	1.19	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	2.34	0.00	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.92	1.92	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	15.24	8.86	6.38	2.13	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.45	6.25	4.69	1.25	2.19	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	11.61	0.73	1.45	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	10.87	7.69	0.53	1.86	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	10.01	8.01	0.50	0.00	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	12.00	6.36	1.23	2.24	0.72	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	2.70	0.00	4.05	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.08	4.68	0.99	1.72	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.07	9.72	0.59	1.18	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.06	6.82	0.62	0.62	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.47	3.11	0.41	1.66	0.21	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.51	6.01	1.00	1.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.03	6.05	0.47	1.40	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.96	5.49	0.41	2.03	1.02	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.73	2.77	0.40	2.77	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.08	5.31	0.88	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.88	7.22	0.00	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	6.58	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.31	3.61	0.42	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	4.60	1.84	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.73	5.96	1.49	1.49	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	5.03	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	3.51	1.51	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.94	3.80	1.90	0.48	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.93	9.40	4.42	2.21	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.84	6.68	2.76	2.76	0.46	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.47	3.79	2.31	2.10	0.42	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.78	5.30	2.85	1.83	0.82	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.15	7.51	1.50	1.93	1.07	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.00	5.11	2.67	2.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.88	6.57	4.60	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.15	4.06	4.06	1.01	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	6.63	13.26	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.07	7.61	3.26	1.36	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.59	4.12	3.53	2.65	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	10.90	5.45	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.40	7.69	3.36	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.21	4.80	4.40	0.80	1.20	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	6.86	0.00	2.74	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.51	6.51	6.01	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	6.12	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.26	9.63	3.07	3.50	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	5.52	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	1.28	4.48	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.21	5.45	4.71	2.98	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	5.57	4.87	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	0.00	2.21	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	6.15	2.39	1.37	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	7.88	5.69	3.06	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.40	5.33	3.55	2.13	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.98	4.49	1.12	1.68	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	5.82	1.25	2.91	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.32	6.41	1.75	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.05	5.13	4.22	0.90	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.51	3.76	1.67	0.83	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	4.62	2.77	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.97	6.26	1.71	1.71	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.37	3.32	1.38	0.55	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.03	3.37	2.59	1.81	1.55	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.01	3.86	1.72	1.72	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.96	3.81	2.54	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.74	5.60	2.67	1.07	0.80	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.77	4.49	2.10	0.60	0.90	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.69	1.70	1.70	0.85	1.13	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.51	4.46	2.87	0.32	1.91	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	10.61	4.20	1.55	1.55	1.33	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.03	3.03	1.14	0.76	1.90	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.65	5.11	2.56	0.85	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.60	3.69	1.97	1.23	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	3.91	0.65	0.00	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.23	5.88	2.65	0.88	2.35	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.55	4.32	0.86	1.15	2.02	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.78	4.12	1.65	2.89	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.12	2.68	1.49	0.60	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	7.13	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.17	4.27	0.33	2.30	1.31	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	4.21	0.00	3.16	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.63	5.54	1.19	1.98	0.59	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	13.97	2.79	1.86	1.86	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.02	4.88	0.75	1.50	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.99	5.33	0.53	1.60	0.53	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.31	3.62	0.23	0.68	0.11	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	5.16	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.19	5.86	0.37	0.73	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	4.67	0.00	6.22	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	11.76	10.69	1.07	1.07	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	8.08	0.00	3.03	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.70	5.90	0.42	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	2.72	1.36	1.36	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	5.72	1.27	1.91	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	5.67	4.86	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	4.53	3.02	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	13.05	9.79	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	30.16	19.17	42.23	5.82	3.66	2.59
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.69	22.47	27.18	6.27	4.18	3.66
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	6.67	2.00	2.00	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	4.59	0.42	0.00	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	16.35	1.71	0.95	0.19	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	4.79	11.17	0.00	7.98	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	0.00	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	31.24	7.35	11.03	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.95	2.09	0.42	1.67	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.39	1.63	0.93	0.00	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	5.67	3.51	0.27	0.27	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.24	2.31	0.42	0.63	0.42	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	11.13	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.93	3.47	0.00	0.00	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.39	2.71	0.27	0.27	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.80	2.49	0.45	0.68	0.00	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.17	2.12	0.33	0.82	0.16	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.30	2.37	0.91	0.73	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	3.18	0.53	0.53	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.80	4.20	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.52	0.98	0.33	0.33	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.37	2.60	0.16	0.65	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.05	4.41	1.23	1.06	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	0.70	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.98	3.68	0.00	0.46	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.43	3.53	0.00	0.32	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.38	2.41	0.69	0.34	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	5.06	5.06	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.71	4.01	1.34	1.11	0.89	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.47	2.96	0.42	1.27	0.42	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.26	2.85	0.71	0.71	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.45	11.16	2.58	1.72	0.43	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	63.19	0.00	9.03	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.33	6.66	2.00	1.67	0.33	2.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	24.35	7.21	3.61	2.25	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	5.56	2.78	2.38	0.40	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	5.57	0.00	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	16.65	3.78	3.03	1.51	0.76	4.54
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.10	13.36	3.58	3.26	0.98	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	5.23	0.87	1.74	1.31	3.49
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.81	11.76	3.62	0.45	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	6.17	3.53	2.65	0.00	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	8.64	3.99	0.00	0.66	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	2.48	0.50	1.49	0.99	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.08	7.27	4.98	2.30	0.38	5.36
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.38	3.02	2.42	0.91	0.60	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.12	9.50	5.75	3.32	0.66	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	9.49	7.45	2.71	2.03	0.68	4.07
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	10.22	20.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.02	10.36	0.61	1.22	1.22	4.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.74	10.70	2.83	1.57	0.63	4.72
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.11	5.45	1.51	1.21	0.00	3.33
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	8.70	0.00	0.79	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	26.07	10.20	4.53	3.40	0.00	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	5.06	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.05	4.72	4.47	1.37	0.99	0.50
Myoblast, donor2	11322-117D8	15.34	5.56	0.96	0.96	0.77	0.77
Myoblast, donor3	11398-118D3	16.48	4.04	2.86	0.67	1.01	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	353.60	68.73	88.29	15.18	16.93	4.52
Natural Killer Cells, donor1	11230-116C6	35.36	8.30	2.15	3.08	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	39.81	6.94	0.60	0.90	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	32.03	5.71	1.10	1.84	0.92	0.55
Neural stem cells, donor1	11275-116H6	39.56	7.26	6.53	2.18	3.99	0.00
Neural stem cells, donor2	11352-117H2	48.14	9.63	5.78	1.93	3.85	0.00
Neurons, donor1	11494-119E9	22.76	6.83	4.55	1.14	4.55	0.00
Neurons, donor2	11574-120E8	26.64	3.96	3.52	1.54	1.76	0.22
Neurons, donor3	11655-122E8	33.71	3.29	1.64	0.82	0.82	0.00
Neutrophils, donor1	11233-116C9	17.63	9.28	1.86	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	8.70	0.00	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	15.88	6.72	0.61	3.67	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	23.03	4.16	0.36	0.83	0.83	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	9.77	2.93	0.33	0.98	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	21.66	10.23	5.82	2.81	1.60	2.01
Olfactory epithelial cells, donor1	11933-125I7	21.75	10.05	2.62	1.24	1.10	3.03
Olfactory epithelial cells, donor2	11934-125I8	24.03	8.40	6.80	1.59	1.16	3.47
Olfactory epithelial cells, donor3	11935-125I9	24.06	9.42	7.60	2.61	1.48	4.31
Olfactory epithelial cells, donor4	11936-126A1	32.53	13.25	6.82	2.34	1.46	4.87
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	6.62	1.81	2.41	2.41	1.81
Osteoblast - differentiated, donor1	11276-116H7	15.31	11.91	9.36	1.91	1.70	5.10
Osteoblast - differentiated, donor2	11353-117H3	13.72	11.43	11.43	3.43	2.29	2.29
Osteoblast - differentiated, donor3	11425-118G3	19.86	11.17	8.69	3.72	1.86	1.86
Osteoblast, donor1	11277-116H8	6.25	2.35	2.54	0.20	0.78	0.00
Osteoblast, donor2	11354-117H4	26.69	6.32	4.92	2.81	0.70	1.40
Osteoblast, donor3	11426-118G4	27.90	7.29	7.11	1.24	1.42	1.42
Pancreatic stromal cells, donor1	11249-116E7	21.31	6.74	2.70	1.77	0.76	1.43
Pericytes, donor1	11491-119E6	3.00	0.45	0.11	0.45	0.11	0.00
Pericytes, donor2	11571-120E5	1.58	0.45	0.68	0.23	0.45	0.00
Pericytes, donor3	11652-122E5	6.10	3.26	1.83	1.22	0.61	0.20
Perineurial Cells, donor1	11499-119F5	26.67	8.36	5.54	1.36	1.92	2.94
Perineurial Cells, donor2	11579-120F4	17.39	5.06	2.12	1.10	0.92	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	37.93	13.71	0.96	7.33	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	25.96	9.79	0.73	1.71	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	28.34	8.80	1.16	2.72	0.65	0.00
Placental Epithelial Cells, donor1	11278-116H9	3.83	2.63	1.43	1.20	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	1.11	1.11	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	8.64	1.96	0.98	0.00	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.03	9.81	7.59	2.53	1.27	4.75
Preadipocyte - breast, donor1	11467-119B9	15.57	16.13	23.07	4.88	1.69	5.82
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	18.53	5.35	23.23	1.17	2.35	0.65
Preadipocyte - breast, donor2	11328-117E5	28.37	15.54	12.16	2.93	1.35	5.40
Preadipocyte - omental, donor1	11468-119C1	22.70	23.66	33.57	8.95	3.30	8.63
Preadipocyte - omental, donor2	11329-117E6	22.70	10.04	12.66	2.18	1.75	5.24
Preadipocyte - omental, donor3	11403-118D8	29.51	13.32	15.76	2.58	3.01	6.16
Preadipocyte - perirenal, donor1	11469-119C2	6.89	5.91	1.97	0.00	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	8.29	4.91	6.45	0.92	0.92	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	26.92	10.09	7.08	1.95	2.12	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	26.05	9.71	7.83	1.53	0.17	1.19
Preadipocyte - visceral, donor1	11280-116I2	25.43	8.66	5.87	2.33	1.12	0.65
Preadipocyte - visceral, donor2	11357-117H7	18.87	9.66	5.52	1.84	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	15.99	7.00	4.08	1.46	1.46	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.49	14.78	12.52	3.77	2.11	0.45
Prostate Epithelial Cells, donor2	11331-117E8	9.61	7.31	1.76	2.57	0.81	0.14
Prostate Epithelial Cells, donor3	11404-118D9	28.54	52.97	22.17	30.19	3.43	2.20
Prostate Stromal Cells, donor1	11254-116F3	27.56	14.47	28.13	3.30	3.42	1.71
Prostate Stromal Cells, donor2	11332-117E9	28.51	16.85	20.98	4.48	3.41	1.97
Prostate Stromal Cells, donor3	11405-118E1	16.37	8.34	6.67	2.82	1.88	3.23
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	4.01	3.28	0.73	2.19	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.51	10.54	4.37	2.63	1.73	0.69
Renal Epithelial Cells, donor1	11517-119H5	2.54	2.54	0.51	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	2.13	2.13	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	24.88	6.99	3.07	0.95	0.85	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	0.68	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.18	2.02	1.08	0.81	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.43	7.10	2.44	1.55	2.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	0.67	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	4.40	1.32	0.66	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	4.39	1.25	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.77	0.55	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	9.13	9.13	6.17	2.15	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.90	8.43	4.64	2.53	1.27	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.36	4.44	2.31	0.58	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.04	6.48	1.81	1.56	1.30	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.25	1.14	0.28	0.28	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.07	13.55	7.28	5.02	0.75	1.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.07	5.21	0.94	2.27	1.07	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	12.51	0.89	3.57	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.81	1.65	2.20	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	1.16	5.80	0.00	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.61	1.95	2.21	0.13	2.08	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	10.33	1.09	1.49	0.40	0.70	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.82	0.78	2.45	0.11	0.78	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.40	2.48	2.85	0.12	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.47	0.82	1.28	0.47	0.93	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	11.56	0.92	1.62	0.00	1.39	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.49	0.41	1.37	0.00	1.51	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	9.98	1.66	1.66	0.45	0.91	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	11.47	0.90	2.69	0.00	1.25	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.32	0.43	1.58	0.57	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	10.30	0.64	2.47	0.00	0.97	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	13.72	0.66	2.21	0.00	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.93	1.15	1.72	0.19	1.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.95	1.21	1.49	0.28	0.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.27	1.13	2.44	0.56	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.54	0.93	2.39	0.13	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.82	1.07	1.27	0.19	1.56	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.37	0.38	1.34	0.19	0.95	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	9.18	1.07	1.71	0.11	1.39	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.13	0.84	2.52	0.28	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	11.45	0.85	0.34	0.00	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.12	2.01	2.01	0.36	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	8.46	0.98	1.47	0.12	1.47	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	10.07	1.34	2.28	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.43	1.18	1.89	0.94	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	12.50	0.79	1.98	0.60	1.19	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	11.22	2.34	1.40	0.00	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.50	0.83	3.11	0.00	0.83	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	12.39	0.88	1.11	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	10.03	0.63	0.84	0.42	0.84	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.09	0.94	2.02	0.67	1.62	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	14.13	1.36	2.72	0.34	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	10.03	0.77	2.51	0.58	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.74	1.38	1.89	0.17	1.89	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	12.07	1.51	2.19	0.27	1.92	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.67	1.48	1.64	0.00	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.52	1.02	1.36	0.00	1.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	13.02	1.18	0.30	0.30	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	6.66	0.80	1.87	0.53	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	13.83	0.97	2.21	0.55	1.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.71	0.71	0.48	0.00	1.43	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	9.27	1.01	0.81	0.20	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.10	0.57	1.04	0.09	1.79	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	19.56	1.75	8.38	1.05	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.53	2.12	5.14	1.21	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.55	0.49	1.71	0.37	1.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	27.65	3.64	12.81	1.02	3.20	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.12	2.43	9.73	0.00	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.95	0.00	2.71	0.00	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.85	1.81	5.43	0.23	2.26	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	25.46	2.40	6.59	1.20	1.20	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.25	0.83	7.79	0.24	2.60	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.34	1.92	5.98	0.00	1.71	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	34.86	3.00	13.22	0.00	1.80	1.20
Schwann Cells, donor1	11498-119F4	6.39	0.94	0.75	0.19	0.75	0.00
Schwann Cells, donor2	11578-120F3	23.82	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.58	3.29	0.88	0.44	1.31	0.00
Sebocyte, donor1	11220-116B5	8.76	4.38	3.29	0.55	1.10	0.00
Sebocyte, donor2	11301-117B5	5.51	6.43	3.68	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	8.04	3.71	0.82	1.44	0.62	0.21
Sertoli Cells, donor1	11255-116F4	46.38	18.22	19.88	3.31	4.97	3.31
Sertoli Cells, donor2	11333-117F1	16.95	11.30	11.30	8.47	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	34.58	30.97	27.80	14.78	4.22	2.38
Skeletal Muscle Cells, donor2	11358-117H8	10.12	10.12	11.57	2.89	2.17	1.45
Skeletal Muscle Cells, donor3	11430-118G8	17.56	3.34	1.67	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	18.22	9.11	1.89	1.41	1.26	0.31
Skeletal Muscle Cells, donor5	11455-119A6	18.58	11.00	2.97	1.34	0.74	0.15
Skeletal Muscle Cells, donor6	11459-119B1	20.47	12.31	3.23	2.31	1.54	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	23.31	6.30	3.28	0.38	1.51	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	19.55	7.56	0.43	0.86	0.86	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	27.48	8.83	2.58	1.49	1.29	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.99	21.32	24.01	6.66	2.19	2.53
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	7.24	13.75	0.72	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.39	1.51	1.24	0.55	0.55	0.14
Skin - palm, donor1	10286-104F7	42.98	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.17	6.20	1.87	1.15	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	5.73	9.81	9.00	6.54	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.06	5.19	2.08	0.91	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	25.16	19.88	15.85	15.99	2.36	1.81
Small Airway Epithelial Cells, donor2	11334-117F2	25.88	19.97	16.32	9.56	3.09	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	18.82	4.44	5.07	4.02	2.96	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	43.32	39.12	19.86	19.94	3.45	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.34	16.35	16.35	4.32	3.39	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.12	9.34	11.78	1.78	1.56	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.93	4.11	1.76	2.94	1.18	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.97	3.76	1.55	0.88	0.44	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.51	3.94	0.79	0.79	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	5.41	0.00	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.38	4.26	1.33	0.67	0.67	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.06	8.42	6.87	1.99	1.77	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.51	14.72	11.01	2.94	2.30	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.00	4.23	1.30	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.31	3.25	1.48	0.89	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.38	5.98	1.57	1.00	0.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.95	1.95	0.00	0.65	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	26.18	16.44	11.87	9.44	3.04	2.44
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.64	5.56	2.53	1.26	0.25	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	2.38	3.81	1.91	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.06	4.28	1.18	1.62	0.88	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.56	7.10	2.58	0.65	1.51	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.11	8.61	3.04	1.26	1.05	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.19	3.56	1.70	0.77	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	2.16	1.08	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.17	2.09	4.18	0.60	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	1.37	0.34	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.79	5.50	2.12	1.02	1.10	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	12.38	9.86	3.93	3.02	0.91	1.71
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.43	8.65	4.78	2.96	0.91	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.62	1.81	1.21	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.08	10.86	5.30	2.91	1.85	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.30	14.11	11.58	3.99	3.33	2.26
Smooth Muscle Cells - Prostate, donor2	11335-117F3	25.29	14.15	12.77	4.01	2.25	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.01	4.31	7.61	1.01	1.27	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.34	9.80	6.78	1.81	1.51	2.56
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	2.25	1.50	0.75	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	2.58	1.29	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.05	5.12	0.47	0.00	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	5.05	1.51	2.52	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.15	7.21	2.82	1.88	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.59	2.95	0.88	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	29.41	10.83	4.58	1.50	1.67	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	11.21	3.27	0.00	0.47	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.76	2.88	2.59	0.58	0.43	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.94	5.10	1.02	1.02	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.08	3.57	1.69	0.56	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.14	4.61	0.84	0.56	0.28	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	23.63	7.96	5.03	1.59	2.43	1.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.79	6.85	2.20	0.49	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	11.93	7.95	4.86	1.10	1.55	4.42
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.77	6.14	9.95	1.46	2.63	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.88	5.83	1.36	1.55	0.00	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.31	6.88	4.76	1.06	1.06	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	4.09	0.74	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	9.34	7.19	1.44	1.44	1.08	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.10	4.26	3.41	1.42	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.39	4.33	5.12	1.18	1.97	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	13.46	8.13	2.54	1.27	0.51	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	9.98	2.80	0.40	1.20	0.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	5.02	2.93	0.84	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	11.92	7.33	2.75	0.92	1.83	2.29
Synoviocyte, donor1	11291-117A4	23.73	9.93	8.25	1.68	1.35	3.03
Synoviocyte, donor2	11368-117I9	26.82	11.40	4.69	1.51	1.34	1.34
Synoviocyte, donor3	11440-118H9	22.34	10.95	4.69	1.79	0.67	2.90
Trabecular Meshwork Cells, donor1	11532-120A2	6.07	1.79	2.50	0.71	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	1.98	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.10	2.55	1.16	0.46	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	17.71	10.32	6.09	4.52	1.22	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	6.57	1.93	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	3.44	2.86	2.86	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	29.77	4.18	0.74	1.97	1.23	0.86
Urethra, donor2	10319-105A4	32.37	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.13	3.45	0.53	0.80	0.27	0.00
Urothelial Cells, donor2	11600-120H7	2.00	1.20	0.40	1.60	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.90	2.29	0.46	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	16.72	9.58	5.13	2.90	2.23	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	29.36	16.91	0.00	1.78	0.89	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	34.31	2.86	0.00	7.15	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	38.33	8.21	0.68	4.11	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	24.79	8.26	0.00	3.10	1.03	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	26.73	6.97	1.16	3.49	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	7.29	0.00	7.29	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.05	11.01	0.92	2.75	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.95	5.48	0.00	3.65	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	28.74	5.67	6.04	0.99	3.08	0.25
Wilms' tumor cell line:HFWT	10597-108E3	80.08	121.45	124.97	42.24	9.68	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	20.95	12.85	8.66	1.40	5.03	0.28
achilles tendon, donor2	10292-104G4	16.53	6.20	4.13	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	63.99	4.84	7.65	0.00	2.29	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	55.95	12.07	6.04	1.63	5.11	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	61.13	3.09	7.72	0.47	3.68	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.89	7.07	5.71	2.18	2.72	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	115.24	26.98	12.37	3.94	4.22	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	29.61	5.71	2.75	0.63	1.90	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	60.16	17.15	26.68	4.63	5.17	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	27.76	7.93	3.97	1.32	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	28.99	5.31	0.82	0.82	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	78.05	10.48	5.82	0.39	6.99	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	16.01	6.44	1.47	0.92	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	47.64	9.53	8.37	1.86	2.56	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.93	27.44	6.21	3.88	2.85	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	55.82	19.29	3.80	2.05	4.09	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	59.95	6.51	3.25	4.18	2.32	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	27.55	5.35	2.47	0.82	1.65	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	14.43	13.81	2.15	1.23	1.23	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	41.82	15.79	7.25	1.71	5.12	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	46.71	17.29	5.76	4.55	2.12	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	45.73	22.87	11.31	5.30	5.78	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	24.06	16.93	5.79	2.23	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	34.02	9.01	10.01	1.33	1.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	178.39	48.31	48.31	1.86	7.43	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	73.07	9.79	18.46	3.39	3.77	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	35.33	4.80	2.18	0.87	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	3.75	15.00	1.87	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	57.46	8.95	2.83	2.83	2.35	0.24
adipose tissue, adult, pool1	10010-101C1	21.10	6.20	0.31	1.86	0.93	0.47
adipose, donor1	10184-103D4	100.86	4.10	2.35	1.17	1.17	1.17
adipose, donor2	10185-103D5	24.33	6.49	1.62	1.22	0.81	0.41
adipose, donor3	10186-103D6	26.68	7.62	2.18	0.82	1.09	0.82
adipose, donor4	10187-103D7	44.20	19.07	10.40	6.07	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	20.04	29.35	8.84	4.73	6.63	0.32
adrenal gland, adult, pool1	10081-102A9	32.74	3.64	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	29.75	4.67	1.73	1.20	1.07	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	23.58	13.58	5.72	3.93	1.79	0.00
amniotic membrane cells, donor1	12235-129G3	17.39	6.49	2.55	1.85	1.16	0.23
amniotic membrane cells, donor2	12236-129G4	13.86	8.45	1.01	1.69	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	13.26	5.60	1.18	1.47	0.59	0.88
amygdala - adult, donor10196	10167-103B5	17.79	4.74	0.00	3.56	4.74	0.00
amygdala, adult, donor10252	10151-102I7	34.06	5.68	0.81	3.04	1.82	0.20
amygdala, newborn, donor10223	10360-105E9	10.65	1.29	0.65	0.97	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	66.08	36.29	26.48	10.70	6.37	9.30
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	41.92	7.06	7.94	1.54	2.87	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	35.41	2.00	1.00	0.33	1.67	0.33
aorta, adult, pool1	10052-101G7	26.28	3.73	0.39	0.78	0.59	0.00
appendix, adult	10189-103D9	46.96	13.20	8.54	3.10	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	39.90	4.13	1.03	0.34	1.03	0.34
artery, adult	10190-103E1	23.10	4.08	0.00	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	48.10	10.58	4.78	2.75	2.17	0.43
b cell line:RPMI1788	10427-106D4	57.70	11.60	7.88	2.68	4.61	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	30.80	11.38	8.32	2.77	3.33	4.44
bile duct carcinoma cell line:HuCCT1	10432-106D9	35.62	25.70	15.78	7.94	3.57	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	39.33	20.09	12.05	11.05	3.85	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	99.54	30.76	18.45	4.47	9.51	2.24
bladder, adult, pool1	10011-101C2	34.00	10.76	0.54	4.13	1.74	0.33
blood, adult, pool1	10053-101G8	26.58	4.43	0.00	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	5.99	5.14	0.00	1.71	0.00
bone marrow, adult	10192-103E3	14.85	10.12	2.70	3.37	1.35	0.00
brain, adult, donor1	10084-102B3	20.50	0.00	0.00	1.03	2.05	0.00
brain, adult, pool1	10012-101C3	21.71	3.34	0.56	1.89	2.23	0.00
brain, fetal, pool1	10085-102B4	24.04	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	58.80	32.38	23.13	5.95	7.60	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	35.57	4.49	1.25	2.00	1.87	0.25
breast, adult, donor1	10080-102A8	27.78	3.16	0.00	0.63	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	44.97	14.48	4.45	11.81	3.18	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	39.27	8.97	2.78	1.55	4.95	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.56	12.89	31.31	3.22	3.45	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.53	1.45	0.24	0.48	1.21	0.24
carcinoid cell line:NCI-H1770	10703-109H1	32.91	9.40	5.17	3.29	3.76	0.00
carcinoid cell line:NCI-H727	10735-110B6	141.32	70.88	170.85	55.35	27.45	2.08
carcinoid cell line:SK-PN-DW	10719-109I8	27.25	4.75	2.54	0.00	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	74.80	14.91	23.42	4.79	5.06	2.13
caudate nucleus - adult, donor10196	10177-103C6	24.18	5.76	1.15	2.30	3.45	1.15
caudate nucleus, adult, donor10252	10164-103B2	30.45	6.19	0.84	1.51	1.51	0.33
caudate nucleus, adult, donor10258	10379-105H1	25.98	2.29	0.00	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	16.85	3.66	1.10	1.83	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	32.05	0.00	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	52.74	6.41	0.64	3.20	1.71	0.00
cerebellum, adult, pool1	10083-102B2	20.35	1.72	0.34	0.34	1.03	0.69
cerebellum, newborn, donor10223	10357-105E6	29.06	2.49	0.83	1.66	4.15	0.00
cerebral meninges, adult	10188-103D8	27.48	5.80	0.25	1.51	1.26	0.50
cerebrospinal fluid, donor2	10294-104G6	16.81	2.19	0.73	0.73	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	87.99	18.84	7.19	6.04	3.45	0.58
cervical cancer cell line:ME-180	10553-107I4	68.94	38.78	47.06	20.22	10.44	3.15
cervix, adult, pool1	10013-101C4	29.71	7.56	0.52	1.99	0.94	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	54.48	10.59	14.21	4.04	3.76	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	33.96	3.92	5.23	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	33.80	28.83	23.49	12.55	3.48	0.37
choriocarcinoma cell line:SCH	10785-110H2	25.87	11.58	9.24	5.67	2.22	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	27.99	10.44	9.49	5.69	3.08	0.00
chorionic membrane cells, donor1	12238-129G6	12.25	1.71	1.42	1.14	1.42	0.00
chorionic membrane cells, donor2	12239-129G7	26.45	8.25	4.08	1.69	1.79	0.80
chorionic membrane cells, donor3	12240-129G8	15.94	2.20	0.00	1.10	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	33.32	12.12	7.07	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	74.15	18.25	7.11	3.27	3.65	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	66.73	7.81	5.07	0.84	3.80	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.30	11.81	4.62	2.05	4.37	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	39.67	12.09	6.53	2.90	3.87	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	39.09	8.14	8.76	2.04	3.26	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	67.72	13.25	14.13	1.47	3.83	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	96.17	17.20	10.16	2.35	5.47	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	40.69	20.80	24.00	5.49	4.80	0.23
clear cell carcinoma cell line:TEN	10636-108I6	31.40	18.74	19.95	8.15	5.38	0.87
colon carcinoma cell line:CACO-2	10513-107D9	38.07	13.18	14.64	1.83	4.39	1.46
colon carcinoma cell line:COLO-320	10420-106C6	39.53	4.94	4.56	1.14	4.94	1.14
colon, adult, donor1	10082-102B1	19.04	4.76	0.00	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	32.67	5.76	0.71	1.29	1.06	0.35
colon, fetal, donor1	10070-101I7	26.57	2.47	0.00	0.62	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	77.92	9.17	9.17	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	79.04	6.80	43.34	7.65	2.55	5.52
cord blood derived cell line:COBL-a 24h infection	10453-106G3	40.15	5.13	12.53	1.96	2.11	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	42.73	6.06	13.26	2.12	2.96	0.56
corpus callosum, adult, pool1	10042-101F6	27.53	8.07	1.33	2.43	3.10	0.44
cruciate ligament, donor2	10295-104G7	20.26	3.24	0.81	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	19.26	4.01	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	22.08	2.64	0.24	1.44	3.60	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	68.65	22.04	20.89	3.44	4.82	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	146.68	57.19	100.52	30.00	10.26	3.33
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	42.13	26.00	62.83	14.44	9.87	2.89
ductus deferens, adult	10196-103E7	30.90	5.48	0.50	2.49	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	4.32	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	26.48	8.83	0.00	0.74	1.47	0.00
dura mater, adult, donor1	10041-101F5	22.71	7.93	1.82	1.82	1.49	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	20.43	8.44	30.87	3.33	2.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.62	10.17	16.19	2.29	1.86	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	60.43	36.38	37.00	11.72	8.02	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	26.94	14.53	11.20	6.05	1.82	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.97	40.75	47.55	16.98	7.10	0.00
embryonic pancreas cell line:2C6	10603-108E9	65.67	27.58	35.46	5.25	11.82	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	38.21	45.25	55.98	37.54	8.38	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	85.36	39.33	82.28	24.10	8.70	5.62
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.12	9.33	5.79	1.77	1.13	0.16
epidermoid carcinoma cell line:A431	10426-106D3	56.25	21.34	16.90	3.67	6.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	31.35	27.28	10.45	7.48	3.41	0.33
epididymis, adult	10197-103E8	17.58	3.77	0.42	1.05	1.26	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	72.21	8.87	25.37	2.84	5.14	3.37
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	73.93	33.03	117.19	16.91	9.83	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	28.44	10.48	6.55	3.15	1.57	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	35.14	13.39	12.79	4.13	2.95	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	32.04	13.44	5.94	3.47	2.80	0.11
esophagus, adult, pool1	10015-101C6	25.27	4.03	0.85	2.02	0.85	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	93.55	51.97	138.26	32.94	14.78	3.13
eye - muscle inferior rectus, donor1	10272-104E2	12.07	2.41	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	18.94	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	0.00	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	12.61	3.44	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	5.83	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	25.42	4.07	1.02	1.27	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	36.16	8.72	7.05	1.15	3.21	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	36.56	14.72	6.89	0.95	2.37	0.00
frontal lobe, adult, pool1	10040-101F4	23.74	4.03	0.47	1.03	1.69	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	63.35	15.01	25.22	5.70	6.61	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.40	11.89	5.21	1.83	3.29	0.09
gall bladder, adult	10198-103E9	24.38	6.52	0.24	2.17	0.72	0.48
gamma delta positive T cells, donor1	11937-126A2	26.31	8.59	0.54	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	38.47	10.46	0.37	0.37	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	33.58	7.18	4.86	2.32	1.69	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	71.95	16.05	37.91	10.83	7.93	1.16
gastric cancer cell line:AZ521	10549-107H9	72.47	20.66	65.42	5.41	9.18	2.46
gastric cancer cell line:GSS	10560-108A2	43.93	20.13	21.05	1.83	4.58	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	64.88	16.45	24.90	6.17	6.40	0.46
giant cell carcinoma cell line:LU65	10487-107B1	26.05	30.64	22.83	8.95	3.79	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	59.62	9.80	4.06	2.52	4.20	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	48.89	11.47	13.22	3.99	3.24	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	21.43	8.87	5.49	0.95	1.69	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.49	8.43	3.79	0.84	1.54	0.70
glioblastoma cell line:T98G	10485-107A8	56.51	15.67	18.76	1.88	3.64	1.77
glioma cell line:GI-1	10413-106B8	93.14	18.45	26.65	3.51	4.39	7.03
globus pallidus - adult, donor10196	10175-103C4	20.41	3.64	0.00	0.73	3.64	0.00
globus pallidus, adult, donor10252	10161-103A8	55.90	10.01	1.46	3.42	2.44	0.49
globus pallidus, adult, donor10258	10367-105F7	23.28	8.22	0.00	0.00	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	14.92	4.80	1.60	3.73	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	24.47	12.24	4.89	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	5.23	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	28.80	5.76	10.24	2.56	1.92	0.64
hIPS +CCl2, biol_rep1	14383-156B9	30.30	52.80	73.46	36.27	5.97	1.38
hIPS +CCl2, biol_rep2	14384-156C1	26.52	58.07	77.28	37.04	7.32	0.00
hIPS +CCl2, biol_rep3	14385-156C2	25.76	63.12	74.71	27.05	7.73	0.64
hIPS, biol_rep1	14380-156B6	5.75	73.30	142.29	44.56	2.87	0.00
hIPS, biol_rep2	14381-156B7	17.83	67.90	74.07	16.46	9.60	0.00
hIPS, biol_rep3	14382-156B8	17.66	11.03	9.93	9.93	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	18.68	4.31	0.86	1.44	2.30	0.00
heart - mitral valve, adult	10205-103F7	25.71	3.59	0.30	1.20	1.20	0.00
heart - pulmonic valve, adult	10206-103F8	22.49	7.06	0.00	3.66	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	33.31	5.83	2.50	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	30.61	7.55	10.20	2.45	2.45	0.20
heart, adult, diseased, donor1	10051-101G6	11.92	2.55	0.00	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	22.08	4.37	0.46	1.15	0.46	0.46
heart, fetal, pool1	10046-101G1	21.25	3.70	0.51	1.03	0.82	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	27.15	10.18	2.78	1.23	2.16	2.78
hepatoblastoma cell line:HuH-6	10633-108I3	228.32	29.73	80.86	7.14	11.89	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	46.96	19.67	20.11	4.09	3.09	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	49.76	19.18	20.03	4.37	4.73	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	49.11	21.83	17.38	5.05	4.04	0.71
hepatoma cell line:Li-7	10484-107A7	49.16	58.05	92.09	25.13	6.45	1.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	63.72	11.56	10.95	1.61	5.23	0.20
hippocampus - adult, donor10196	10169-103B7	19.87	2.84	0.95	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	44.49	5.10	0.20	3.27	4.29	0.82
hippocampus, adult, donor10258	10374-105G5	5.48	3.49	0.50	1.49	2.49	0.00
hippocampus, newborn, donor10223	10363-105F3	10.93	1.06	1.06	0.70	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	45.78	66.53	32.35	16.48	6.10	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	32.59	47.13	28.28	16.49	2.75	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	28.94	50.78	27.42	14.47	3.05	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.78	9.59	2.82	4.51	1.69	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	36.15	11.10	3.61	3.36	2.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.58	8.73	2.66	1.52	1.52	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	28.03	4.09	3.50	3.50	0.88	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	30.59	6.68	3.66	1.51	1.94	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.02	3.34	5.84	1.25	1.25	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	30.55	3.79	2.84	0.71	1.89	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	26.36	4.98	2.09	0.64	2.09	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	35.69	3.37	2.02	0.00	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.76	48.82	18.78	13.46	1.72	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.63	45.20	21.13	13.76	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	33.16	49.75	22.69	19.20	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	42.76	6.68	1.34	0.38	1.72	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	35.76	6.11	3.05	2.62	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	45.48	8.00	4.50	1.50	1.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	33.16	6.03	1.51	1.88	2.07	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	28.19	12.28	0.45	1.36	1.36	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.06	3.76	1.57	2.19	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.35	1.80	1.63	1.14	1.31	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.68	2.32	2.03	0.58	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	22.72	3.29	1.79	0.30	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	31.59	39.17	21.43	12.01	2.77	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	24.53	40.23	19.11	10.56	2.85	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.11	47.36	26.95	12.25	4.08	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	36.62	7.75	3.17	2.82	0.70	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	28.19	9.50	2.22	2.85	1.27	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.05	7.87	3.33	2.72	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.20	7.76	2.07	1.55	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.26	2.66	0.66	1.33	2.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	23.60	2.57	1.54	1.03	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.71	1.53	2.30	0.77	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	26.50	1.51	4.54	1.51	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.15	4.70	2.35	0.00	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.19	40.33	18.35	11.35	2.17	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	36.10	47.69	24.51	11.59	3.12	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.93	40.49	16.59	12.20	3.41	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	32.70	8.25	2.14	2.14	2.14	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	146.40	9.76	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.07	3.31	1.65	0.00	0.99	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	33.39	6.57	1.64	1.64	2.19	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	22.44	5.07	1.81	1.45	1.45	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	20.28	3.91	2.85	0.36	1.42	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	2.39	1.19	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.03	4.33	2.03	0.27	1.35	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.20	3.23	1.62	0.54	0.81	0.00
immature langerhans cells, donor1	11904-125F5	13.08	8.96	1.70	1.45	1.21	0.97
immature langerhans cells, donor2	11905-125F6	13.47	3.96	0.79	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	21.77	3.12	0.19	1.14	0.76	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	18.21	3.90	0.98	3.90	0.65	0.65
kidney, adult, pool1	10017-101C8	23.73	7.51	1.00	1.90	1.00	0.90
kidney, fetal, pool1	10045-101F9	22.92	5.02	0.92	1.49	0.85	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	53.54	11.93	10.79	5.68	4.83	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.07	8.99	2.35	1.52	0.69	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	72.12	90.83	107.71	44.04	18.35	4.77
left atrium, adult, donor1	10079-102A7	12.53	0.00	0.00	2.18	0.00	0.00
left ventricle, adult, donor1	10078-102A6	13.15	1.01	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	41.04	8.76	9.03	0.55	4.38	0.00
leiomyoma cell line:10964C	10569-108B2	4.31	5.39	0.36	0.72	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	3.80	5.43	2.17	1.09	0.00	0.54
leiomyoma cell line:15425	10571-108B4	8.74	5.10	1.70	0.97	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	12.70	19.05	6.35	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	27.18	9.41	4.18	0.00	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	121.01	34.35	44.63	7.67	7.08	1.77
liposarcoma cell line:KMLS-1	10782-110G8	15.93	3.91	0.78	1.41	0.47	0.47
liposarcoma cell line:SW 872	10726-110A6	30.58	7.07	1.46	1.10	2.19	0.37
liver, adult, pool1	10018-101C9	35.98	11.83	8.43	1.78	2.43	1.30
liver, fetal, pool1	10086-102B5	15.05	2.82	0.00	0.94	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	28.00	3.94	1.02	1.46	2.48	0.58
locus coeruleus, adult, donor10252	10165-103B3	34.70	7.94	1.48	2.03	2.03	0.92
locus coeruleus, adult, donor10258	10375-105G6	9.31	1.69	0.00	0.85	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	12.62	4.21	3.36	2.94	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	53.42	55.36	123.86	23.11	11.90	2.77
lung adenocarcinoma cell line:PC-14	10408-106B3	17.24	7.58	0.69	0.00	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	63.54	16.48	9.23	6.33	5.80	0.26
lung, adult, pool1	10019-101D1	25.04	7.09	1.65	2.24	1.54	0.12
lung, fetal, donor1	10068-101I5	34.25	11.70	1.71	2.28	2.28	0.29
lung, right lower lobe, adult, donor1	10075-102A3	23.83	7.79	0.92	4.12	0.92	0.00
lymph node, adult, donor1	10077-102A5	21.77	5.21	0.47	1.42	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	39.67	6.14	3.29	1.53	1.75	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	37.28	4.98	9.96	0.75	1.66	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	103.64	19.54	56.07	24.64	11.89	1.70
mature adipocyte, donor1	12231-129F8	38.18	15.54	3.55	4.00	3.11	0.89
mature adipocyte, donor2	12232-129F9	35.90	8.30	4.15	4.77	2.49	1.25
mature adipocyte, donor3	12233-129G1	26.31	9.25	1.66	3.56	3.08	0.71
mature adipocyte, donor4	12234-129G2	35.27	11.32	2.37	2.63	1.84	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	108.65	24.30	18.58	13.10	6.91	3.10
medial frontal gyrus - adult, donor10196	10170-103B8	20.30	0.00	1.13	1.13	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	28.69	3.68	0.37	2.21	1.10	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	10.48	1.59	0.00	0.32	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	14.93	4.26	4.26	0.43	2.13	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	26.16	4.05	0.51	0.17	1.18	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	34.80	8.91	0.64	1.70	1.27	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	1.93	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	11.84	0.72	4.67	0.00	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	24.01	5.84	0.65	1.30	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	36.22	8.20	1.08	2.79	2.01	0.77
medulla oblongata, adult, pool1	10038-101F2	24.49	5.31	0.65	2.61	1.80	0.24
medulla oblongata, newborn, donor10223	10361-105F1	14.23	3.47	1.04	1.74	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	30.78	3.54	3.10	1.33	3.32	0.00
medulloblastoma cell line:ONS-76	10759-110E3	34.36	12.11	3.79	1.83	1.83	0.24
melanoma cell line:COLO 679	10514-107E1	32.63	4.74	13.66	3.02	1.87	2.44
melanoma cell line:G-361	10465-106H6	36.10	5.43	4.07	0.54	1.36	0.27
meningioma cell line:HKBMM	10691-109F7	33.11	28.40	12.12	6.33	1.99	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	46.70	1.76	4.41	0.00	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	47.96	3.89	4.15	0.26	2.59	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.17	8.13	3.68	1.23	1.23	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	38.90	13.63	15.81	2.00	3.64	3.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	15.74	15.32	10.35	1.66	1.66	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.05	7.59	2.81	0.84	0.56	1.69
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.72	7.70	1.54	0.96	0.39	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	16.66	9.02	2.78	1.39	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.66	22.31	27.98	6.52	4.63	7.04
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.37	12.77	10.70	2.76	1.61	4.14
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.58	4.77	2.52	1.19	1.46	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	14.99	5.67	3.51	1.62	1.76	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	19.92	8.68	6.40	1.42	2.13	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.01	16.47	20.75	5.60	3.95	5.27
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.37	7.61	4.15	1.52	1.66	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.64	3.84	5.24	0.70	2.09	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.19	7.35	4.08	2.04	0.61	3.67
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.53	10.06	8.99	3.59	1.08	3.24
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.90	5.28	0.21	0.31	0.72	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.79	8.21	2.28	0.91	1.14	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	23.50	7.55	5.87	3.78	3.36	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.35	4.18	2.54	0.45	0.60	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.16	8.93	7.62	2.10	1.14	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.04	15.83	11.41	4.79	2.21	3.31
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.02	9.44	4.86	1.14	1.14	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	2.53	1.26	0.42	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.90	9.59	10.50	3.65	1.83	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.23	12.02	10.23	4.09	4.35	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	25.13	12.56	12.04	2.09	3.14	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	10.78	14.48	1.54	2.77	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.24	10.36	10.59	2.35	1.88	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	20.65	12.18	11.51	3.05	4.74	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	11.00	9.82	1.18	3.54	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.54	9.27	10.19	2.32	1.39	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.40	14.13	9.52	2.60	2.60	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	20.08	12.27	12.27	0.45	2.45	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.95	10.58	11.30	4.33	2.64	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	31.53	15.40	13.20	2.20	2.20	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	16.78	9.40	9.40	2.69	1.68	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.29	8.19	8.19	1.64	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	20.19	10.74	9.88	2.58	3.01	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	16.41	8.20	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	15.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.76	7.15	12.99	0.97	1.30	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	14.55	10.18	5.82	2.91	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.59	10.66	9.06	1.07	3.20	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	15.54	5.72	11.45	3.27	0.82	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	24.49	9.33	10.88	1.55	1.55	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	8.39	12.59	0.00	10.49	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	10.93	10.93	0.99	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	9.53	38.14	9.53	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.20	13.05	10.08	1.19	0.59	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	17.06	3.66	7.31	3.66	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.20	6.33	7.60	1.90	2.53	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.56	8.97	7.93	2.07	1.03	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	6.45	4.30	4.30	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	11.98	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	10.33	6.89	3.44	3.44	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.82	6.93	4.07	2.04	2.44	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	12.71	2.38	3.97	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	7.07	3.54	1.18	0.00	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.04	5.61	2.49	1.25	1.25	2.49
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	9.36	5.35	4.01	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	2.37	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	10.27	5.14	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.77	6.20	1.38	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.38	3.96	0.49	1.48	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	4.49	3.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	1.27	0.00	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.27	4.84	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	4.36	4.36	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	3.80	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	28.52	19.42	23.67	5.46	5.46	5.46
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	18.08	4.52	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	21.42	14.83	9.06	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.69	6.55	4.96	2.38	1.19	2.78
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.55	4.54	4.87	3.24	0.97	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	6.11	3.06	0.00	0.00	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.82	10.06	16.25	2.32	1.55	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	65.91	32.60	17.72	11.34	8.74	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.09	9.96	5.10	3.24	1.16	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	21.37	4.27	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	12.23	9.14	5.75	2.06	0.41	0.21
mesothelioma cell line:Mero-25	10850-111F4	26.55	40.62	85.79	20.43	7.72	0.91
mesothelioma cell line:Mero-41	10851-111F5	20.78	8.31	5.13	1.71	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	13.95	10.41	2.88	3.99	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	33.90	11.04	23.92	2.89	5.52	2.63
mesothelioma cell line:Mero-83	10854-111F8	15.49	15.15	4.77	2.04	1.70	0.17
mesothelioma cell line:Mero-84	10855-111F9	6.82	15.17	8.09	2.53	2.02	0.00
mesothelioma cell line:Mero-95	10856-111G1	23.19	10.15	4.14	2.48	0.83	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	25.51	16.07	15.90	4.14	2.32	0.17
mesothelioma cell line:NCI-H226	10846-111E9	13.03	7.06	3.62	1.81	1.45	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	14.18	5.47	2.56	1.54	1.71	0.51
mesothelioma cell line:NCI-H28	10845-111E8	20.61	25.45	26.46	3.56	5.09	0.51
mesothelioma cell line:No36	10857-111G2	7.18	5.55	2.61	1.30	1.63	0.00
mesothelioma cell line:ONE58	10858-111G3	13.82	2.98	1.90	0.27	1.35	0.00
migratory langerhans cells, donor1	11901-125F2	17.46	2.69	0.38	0.19	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	14.41	3.30	0.12	1.34	0.61	0.00
migratory langerhans cells, donor3	11903-125F4	21.00	1.97	0.36	0.36	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	32.97	83.25	35.91	46.69	5.22	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.27	12.72	4.66	1.27	1.27	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	122.55	94.45	173.46	46.07	20.96	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.21	4.38	2.47	1.52	1.14	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	73.92	18.85	4.99	4.44	3.51	0.00
myeloma cell line:PCM6	10474-106I6	111.09	5.93	3.56	2.37	3.76	2.77
myxofibrosarcoma cell line:MFH-ino	10600-108E6	40.58	6.09	4.57	0.51	5.58	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.60	5.10	2.94	1.57	1.18	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.31	49.14	21.95	42.90	5.57	1.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	28.75	44.49	17.06	36.99	4.04	0.74
nasal epithelial cells, donor2	12227-129F4	38.09	15.46	6.62	10.49	2.21	0.55
neuroblastoma cell line:CHP-134	10508-107D4	85.12	11.73	30.14	3.91	9.20	3.45
neuroblastoma cell line:NB-1	10539-107G8	43.97	11.41	8.23	1.50	2.43	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	83.93	8.86	34.59	4.64	7.17	0.84
neuroblastoma cell line:NH-12	10555-107I6	41.18	6.71	3.35	1.12	1.86	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	27.99	2.61	2.14	0.95	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.42	7.76	11.25	2.53	2.69	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	24.35	5.64	3.02	1.41	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	114.44	17.17	27.34	6.99	12.08	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	30.08	10.91	10.38	2.66	2.13	2.13
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	89.63	6.93	8.79	1.35	2.88	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	44.83	4.00	4.00	4.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	30.14	13.79	9.30	3.21	1.92	3.85
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.98	5.52	3.42	1.58	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	23.62	3.75	0.56	0.94	1.87	0.19
occipital cortex - adult, donor10196	10172-103C1	22.66	6.18	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	47.23	6.44	2.15	1.88	1.34	0.54
occipital cortex, newborn, donor10223	10355-105E4	13.10	1.46	3.28	0.36	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	22.04	2.62	0.26	2.10	1.57	0.26
occipital lobe, fetal, donor1	10073-102A1	24.46	0.86	0.43	0.43	0.43	0.00
occipital pole, adult, pool1	10036-101E9	10.49	1.97	0.16	0.47	1.26	0.08
olfactory region, adult	10195-103E6	15.09	5.16	0.57	1.53	2.67	0.38
optic nerve, donor1	10277-104E7	40.02	4.00	0.00	8.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	48.41	35.43	21.76	9.23	3.65	3.99
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	58.53	36.82	29.95	9.07	7.97	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.85	19.30	6.94	3.39	1.86	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	54.52	20.68	14.32	7.85	2.66	2.31
osteoclastoma cell line:Hs 706.T	10704-109H2	47.03	17.93	18.81	3.23	4.41	3.82
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	170.98	24.29	30.83	7.47	17.75	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	41.35	14.00	17.81	3.61	2.33	2.33
ovary, adult, pool1	10020-101D2	29.18	4.54	0.79	2.36	1.57	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.10	4.77	2.20	0.55	3.67	0.18
pancreas, adult, donor1	10049-101G4	43.27	2.82	0.00	0.00	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	19.01	13.98	5.59	3.91	1.12	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	39.01	13.46	10.56	2.38	1.70	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	23.35	5.30	2.48	1.99	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	19.04	3.11	0.18	1.19	1.83	0.64
parietal cortex, adult, donor10258	10373-105G4	9.54	4.40	2.20	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	17.87	0.00	0.94	0.00	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	25.65	6.56	1.43	2.00	2.28	0.29
parietal lobe, adult, pool1	10034-101E7	18.51	3.35	0.53	1.15	1.67	0.09
parietal lobe, fetal, donor1	10072-101I9	28.13	0.97	0.97	1.94	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.59	0.75	1.50	1.12	0.37	0.00
parotid gland, adult	10199-103F1	35.15	5.55	0.00	3.70	0.00	0.62
penis, adult	10200-103F2	19.34	4.83	0.00	3.22	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	71.96	16.36	5.95	13.76	4.09	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.56	25.35	12.24	7.58	3.06	1.17
pineal gland - adult, donor10196	10179-103C8	36.77	3.23	0.00	1.94	5.81	0.00
pineal gland, adult, donor10252	10160-103A7	75.80	4.74	0.00	3.55	2.37	0.59
pineal gland, adult, donor10258	10377-105G8	33.86	3.76	0.63	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	27.32	5.06	1.01	1.01	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	67.75	6.25	2.08	2.61	1.04	1.04
pituitary gland, adult, donor10258	10378-105G9	26.39	5.11	0.00	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	18.81	4.30	1.08	0.97	0.86	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	44.89	17.88	19.73	3.84	3.31	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.99	4.51	1.40	0.16	0.47	0.31
pons, adult, pool1	10033-101E6	18.50	3.10	0.43	1.55	1.12	0.26
postcentral gyrus, adult, pool1	10032-101E5	17.70	3.57	0.17	1.05	1.83	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	8.37	4.18	4.18	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	44.72	34.38	24.62	5.83	6.55	1.31
prostate cancer cell line:PC-3	10439-106E7	27.41	10.89	4.17	2.90	2.36	0.18
prostate, adult, pool1	10022-101D4	31.83	6.35	0.82	2.90	2.45	0.63
putamen, adult, donor10196	10176-103C5	30.22	2.83	0.24	1.65	3.07	0.24
putamen, adult, donor10252	10152-102I8	33.33	1.96	0.00	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	16.39	46.99	12.02	7.65	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	21.26	2.90	0.00	0.97	1.45	0.48
putamen, newborn, donor10223	10365-105F5	9.75	3.00	1.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	164.96	32.00	58.77	21.24	19.20	1.16
rectum, fetal, donor1	10067-101I4	48.68	6.95	0.00	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	10.39	3.82	0.42	0.85	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.55	6.63	4.97	2.07	3.73	2.49
retina, adult, pool1	10030-101E3	26.84	5.27	0.60	2.19	1.59	0.30
retinoblastoma cell line:Y79	10475-106I7	61.57	6.50	7.27	1.56	3.64	2.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	34.43	3.07	5.29	0.37	2.58	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	134.98	14.34	41.90	6.19	12.94	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	37.13	6.82	6.82	1.52	4.55	0.00
salivary acinar cells, donor1	11771-123I7	16.83	4.86	0.97	1.78	0.49	0.49
salivary acinar cells, donor2	11772-123I8	18.86	5.23	0.41	2.20	0.69	1.10
salivary acinar cells, donor3	11773-123I9	41.71	5.96	0.66	1.32	0.66	0.00
salivary gland, adult, pool1	10093-102C3	25.74	4.58	1.14	2.29	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.17	16.19	9.11	5.90	2.28	1.43
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	49.96	16.81	8.82	5.52	2.59	1.65
seminal vesicle, adult	10201-103F3	28.04	4.76	0.00	0.53	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.02	2.67	2.67	1.21	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.10	19.38	9.81	4.28	2.26	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	20.07	24.08	6.02	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	22.97	2.82	3.63	1.07	3.22	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	121.80	29.40	101.46	21.55	13.48	1.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	20.13	10.32	13.42	2.19	2.19	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	19.15	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	17.99	1.56	0.24	0.72	1.20	0.12
skeletal muscle, fetal, donor1	10066-101I3	12.06	1.01	0.00	0.00	3.02	0.00
skin, adult, donor1	10074-102A2	13.57	20.36	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	20.83	1.89	0.00	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.36	6.34	6.00	1.00	4.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	82.58	7.25	3.78	2.52	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	63.03	9.06	15.23	2.31	6.75	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	109.45	11.54	24.56	3.13	5.93	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	38.60	20.43	8.53	2.73	6.11	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.72	7.85	14.38	2.62	5.23	1.09
small intestine, adult, pool1	10024-101D6	32.85	3.46	0.36	1.43	0.84	0.24
small intestine, fetal, donor1	10064-101I1	20.88	2.95	0.49	0.00	1.23	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.13	5.13	2.56	1.54	0.00	2.05
smooth muscle, adult, pool1	10048-101G3	34.89	8.01	0.00	1.29	2.33	0.52
somatostatinoma cell line:QGP-1	10781-110G7	40.47	10.72	6.70	2.68	2.68	0.54
spinal cord - adult, donor10196	10181-103D1	32.12	5.51	0.92	1.38	1.38	0.69
spinal cord, adult, donor10252	10159-103A6	45.34	13.41	1.58	6.70	2.76	1.18
spinal cord, adult, donor10258	10369-105F9	10.38	6.23	0.00	2.77	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	20.12	1.22	0.00	0.61	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	22.96	5.51	0.92	1.84	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	46.30	15.08	17.33	4.03	4.93	2.69
spleen, adult, pool1	10025-101D7	26.43	7.82	3.08	1.65	0.99	0.33
spleen, fetal, pool1	10044-101F8	18.59	3.65	1.43	1.27	0.64	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	53.00	7.14	11.90	1.04	4.04	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	82.22	71.77	43.10	28.86	10.25	2.47
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	45.43	23.41	23.41	10.48	8.74	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	78.58	35.57	16.81	18.76	5.08	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	72.49	11.48	2.93	3.60	3.71	1.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.76	22.03	20.33	5.93	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	48.65	14.38	18.19	0.85	4.23	0.42
stomach, fetal, donor1	10062-101H8	41.65	5.34	0.00	0.00	3.20	1.07
submaxillary gland, adult	10202-103F4	29.05	5.13	0.00	2.28	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	36.14	8.10	0.83	3.74	1.45	0.42
substantia nigra, adult, donor10258	10371-105G2	8.79	3.62	0.52	0.52	2.59	0.52
substantia nigra, newborn, donor10223	10358-105E7	9.19	4.24	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	56.17	9.40	8.02	2.06	2.52	0.23
temporal lobe, adult, pool1	10031-101E4	11.95	3.14	0.42	0.68	0.76	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	27.07	1.42	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.02	3.52	0.88	0.44	0.88	0.00
tenocyte, donor1	11763-123H8	12.22	4.89	1.05	1.75	1.05	1.05
tenocyte, donor2	11765-123I1	14.88	6.49	2.67	0.76	1.14	0.00
tenocyte, donor3	11768-123I4	14.83	9.27	0.74	1.11	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	65.26	38.75	42.66	17.17	5.10	3.40
teratocarcinoma cell line:NCR-G1	10798-110I6	27.44	3.55	1.85	0.46	0.62	0.15
teratocarcinoma cell line:PA-1	10807-111A6	60.13	41.84	38.74	12.86	5.89	1.70
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	65.12	144.85	227.62	126.69	16.50	2.54
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	107.02	381.95	495.41	500.70	22.69	4.92
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	95.76	419.78	416.29	820.15	23.88	5.23
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	113.34	24.43	38.11	51.79	9.77	1.63
testis, adult, pool1	10026-101D8	26.09	5.48	1.29	2.25	3.97	0.43
testis, adult, pool2	10096-102C6	23.91	8.57	1.80	2.26	2.26	0.00
thalamus - adult, donor10196	10168-103B6	32.02	7.73	2.21	2.21	3.31	0.00
thalamus, adult, donor10252	10154-103A1	40.95	10.78	0.31	2.97	2.81	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	12.32	0.00	1.54	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.20	1.15	0.16	0.00	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	9.21	1.73	0.00	0.58	0.00	0.00
throat, adult	10209-103G2	18.23	4.49	1.00	2.00	0.50	0.25
throat, fetal, donor1	10061-101H7	28.95	4.88	0.00	0.61	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	30.21	2.58	1.99	0.40	3.38	0.00
thymus, adult, pool1	10027-101D9	41.95	10.84	3.68	1.59	1.49	0.50
thymus, fetal, pool1	10043-101F7	30.65	7.17	2.91	2.81	0.73	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.53	13.96	16.09	2.53	3.86	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	50.15	24.03	18.30	7.26	3.77	1.26
thyroid, adult, pool1	10028-101E1	41.43	6.91	1.12	2.89	1.49	0.37
thyroid, fetal, donor1	10060-101H6	27.42	3.95	0.26	2.11	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	17.21	3.02	0.47	1.63	0.47	0.00
tongue, fetal, donor1	10059-101H5	22.07	1.97	0.00	1.18	1.18	0.00
tonsil, adult, pool1	10047-101G2	32.66	8.01	4.51	1.90	0.40	0.70
trachea, adult, pool1	10029-101E2	25.36	7.44	1.23	1.64	1.47	0.25
trachea, fetal, donor1	10058-101H4	26.16	6.16	0.38	2.31	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	29.76	6.02	10.27	1.42	3.19	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	46.00	9.22	8.92	0.91	2.53	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	134.59	21.78	60.32	8.93	11.12	4.70
tridermal teratoma cell line:HGRT	10694-109G1	70.39	3.81	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	53.16	25.65	39.02	11.17	6.18	4.91
umbilical cord, fetal, donor1	10057-101H3	16.69	2.09	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	22.01	7.51	0.34	3.92	2.05	0.17
uterus, fetal, donor1	10055-101H1	27.13	5.12	0.00	1.54	2.05	0.00
vagina, adult	10204-103F6	34.89	5.17	2.58	1.94	1.29	0.00
vein, adult	10191-103E2	25.65	8.77	0.88	1.10	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.17	6.14	6.94	1.07	1.34	0.80

Property "Nearest transcripts" (as page type) with input value "ENST00000640382.1:-2 ENST00000640041.1:-2 ENST00000519704.1:116 ENST00000518310.5:128 ENST00000517351.5:132 M81601:143 ENST00000522635.5:173 AK297729:173 ENST00000521086.6:177 BX538034:177 AK297957:179 AK026617:183 X57198:189 BC072460:191 GQ900953:191 X62585:213 ENST00000518784.5:283 ENST00000520534.5:294 AK290454:299 ENST00000640873.1:317 ENST00000638322.1:317 CR542221:317" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.